Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Bone Biologics Corp BBLG

Bone Biologics Corporation is a medical device company. The Company is focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. The NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. The NELL-1/DBM Fusion Device offers a range of procedures... see more

NDAQ:BBLG - Post Discussion

Bone Biologics Corp > Bone Biologics Effects 1-for-30 Reverse Stock Split
View:
Post by whytestocks on Jun 06, 2023 7:30pm

Bone Biologics Effects 1-for-30 Reverse Stock Split

JUST IN: $BBLG Bone Biologics Effects 1-for-30 Reverse Stock SplitBone Biologics Corporation (NASDAQ: BBLG) , a developer of orthobiologic products for spine fusion markets, announces that a 1-for-30 reverse stock split became effective on June 5, 2023 and that its common stock and warrants will begin trading on a split-adjusted basis with the open of the m...BBLG - Bone Biologics Effects 1-for-30 Reverse Stock Split
Be the first to comment on this post